Alivus Life Sciences share price
ALIVUS on NSE · data as of 16 Oct 2026
Alivus Life Sciences closed at ₹1,309.50 on 16 Oct 2026 (−2.41% on the day). It is 12.3% below its 52-week high of ₹1,493.80 (31 Aug 2026) and 68.0% above its 52-week low of ₹779.54 (22 Jan 2026). The stock has outperformed the Nifty 50 over the past year (+47.3% vs -8.5%). It is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 39 (neutral zone).
Technical snapshot
- 20-day averagebelow, 3.9%
- 50-day averagebelow, 4.5%
- 200-day averageabove, 19.1%
- RSI (14)39 neutral zone
- MACDbelow signal line
- Streakdown 2 days in a row
- Typical daily move1.1% last 20 days
- Beta vs Nifty 500.52 moves less than the market
- Traded value today₹4.8 cr 0.3x the 20-day average volume
- Delivery53% 20-day avg 57%
Key levels
- Nearest resistance₹1,398.00 6.8% above
- Nearest support₹1,298.00 0.9% below
- Position in 52-week range74% 0 = low, 100 = high
Weekly pivot levels
Chart pattern
Double bottom
Price fell to about the same low twice and bounced both times. Trough level about ₹1,298.00 (16 Sept 2026, 9 Oct 2026); neckline ₹1,446.00.
Forming: price is between the neckline and the troughs.
Support and resistance are recent swing lows and highs; pivots come from last week's high, low and close. Patterns and candles describe past prices only. They are not predictions or buy/sell signals. See the glossary for terms.
Where the price sits
Last 12 months
Weekly closing prices, adjusted for splits and bonus issues.
Returns vs Nifty 50
| Period | ALIVUS | Nifty 50 | Gap |
|---|---|---|---|
| 1 week | −1.3% | +2.8% | −4.1 pts |
| 1 month | −4.5% | −0.3% | −4.2 pts |
| 3 months | +15.5% | −4.9% | +20.4 pts |
| 6 months | +22.2% | −4.3% | +26.5 pts |
| 1 year | +47.3% | −8.5% | +55.8 pts |
Gap = the stock's return minus the Nifty 50's, in percentage points. New to these terms? See 52-week high, moving average and RSI.
Quick answers
What is the 52-week high of Alivus Life Sciences?
The 52-week high of Alivus Life Sciences (ALIVUS) is ₹1,493.80, reached on 31 Aug 2026. The 52-week low is ₹779.54, on 22 Jan 2026 (NSE, as of 16 Oct 2026).
How has Alivus Life Sciences performed in the last year?
Over the last year the share price has moved +47.3%, compared with -8.5% for the Nifty 50 (as of 16 Oct 2026). Past returns do not predict future returns.
Does Alivus Life Sciences show a chart pattern?
Double bottom (forming): level about ₹1,298.00, neckline ₹1,446.00, based on prices up to 16 Oct 2026. Chart patterns describe past prices and often fail.
Is Alivus Life Sciences in an uptrend?
As of 16 Oct 2026, Alivus Life Sciences is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 39 (neutral zone). Trend describes the past, not what happens next.
Price facts only, refreshed every trading day. Not a recommendation to buy or sell. Education only. Not investment advice. All stocks · Today's stock lists